![](/img/cover-not-exists.png)
Phase I evaluation of the combination 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and dianhydrogalactitol (DAG; NSC-132313) in patients with advanced neoplastic diseases
Dr Edward T. Creagan, Robert T. Eagan, Joseph RubinVolume:
7
Year:
1979
Language:
english
Pages:
2
DOI:
10.1002/mpo.2950070212
File:
PDF, 127 KB
english, 1979